Sidra Medicine and Rasmal Ventures Partner to Drive Digital Health Innovation in Qatar
Advancing Healthcare Through E-health Innovation and Startup Integration 25 February 2025, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Rasmal Ventures, Qatar’s first venture capital firm. The strategic partnership, announced at the Web Summit Qatar 2025, marks a significant step in the hospital’s role in supporting and advancing digital health innovation in Qatar and beyond. Rasmal Ventures, with its extensive portfolio of global technology companies, will introduce Sidra Medicine to high-potential e-health startups and provide strategic support to incorporate innovative solutions into Sidra Medicine’s operations. In return, Sidra Medicine will contribute its clinical and research expertise to evaluate and refine the startups’ healthcare technologies, ensuring they are effective, scalable, and patient-focused. Moreover, the two organizations will develop entrepreneurship programs that encourage the development and growth of a Health-Tech sector for Qatar. Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine said: “This partnership highlights our commitment to establishing Sidra Medicine as a leading healthcare innovation hub in Qatar, in alignment with the Qatar National Vision 2030. By collaborating with Rasmal Ventures, we are building upon our current strengths in clinical care, genomics and cell and gene therapy, and taking a proactive approach to adopting innovative technologies and transforming Sidra Medicine into a living lab for entrepreneurial ventures from across Qatar and the world.” The MOU establishes a collaborative framework between the two entities to facilitate the exchange of expertise and best practices in e-health innovations. Through this partnership, Sidra Medicine and Rasmal Ventures aim to drive advancements in innovation, focusing on digital healthcare solutions such as patient-centric artificial intelligence (AI) technologies, telemedicine platforms, and wearable devices. Alexander Wiedmer, Co-Managing Partner at Rasmal Ventures said: “At Rasmal Ventures, we believe that innovation is key to transforming healthcare. Our partnership with Sidra Medicine represents a unique opportunity to bring the latest digital health technologies to the forefront, empowering Qatar’s healthcare system to deliver smarter, more efficient, and patient-centered care.” As part of the agreement, the two entities will host joint workshops, pilot studies, and discussions to validate the efficacy of emerging technologies and foster an open environment for innovation. This partnership positions Sidra Medicine as a driving force in healthcare innovation, creating valuable opportunities for biotech and healthtech leaders. It also underscores Sidra Medicine’s role as a premier destination for medical education and research, attracting innovators and nurturing the development of next-generation healthcare solutions.
Paris Saint-Germain Launches PSG Labs: A Global Innovation Hub with First International Expansion in Doha, QATAR
Paris Saint-Germain (PSG) announced today at Web Summit Qatar that the club is taking a bold step into the future of sports innovation with the launch of PSG Labs, a pioneering global initiative designed to accelerate cutting-edge technology in sports, fan experience, and performance. PSG Labs will serve as the Club’s dedicated innovation engine, identifying and supporting high-potential startups, entrepreneurs, and tech partners to create transformative solutions that will redefine the industry. As part of its commitment to driving innovation, Paris Saint-Germain also announced the club is expanding its global footprint with the launch of its first international PSG Lab in Doha, reinforcing its role as a leader in sports technology and fostering new collaborations in one of the world’s fastest-growing tech ecosystems and a strategic gateway to cutting-edge research and technology in the Middle East. “Paris Saint-Germain has always been at the forefront of innovation—both on and off the pitch,” said Nasser Al-Khelaïfi, President of Paris Saint-Germain. “PSG Labs is a natural extension of our ambition to shape the future of sports. By collaborating with the brightest innovators from around the world, we can accelerate game-changing ideas and further solidify our position as a global leader in innovation. With our first international PSG Lab in Doha, our goal is to drive innovation on a global scale and set new benchmarks for the entire sports industry.” A New Model for Sports Innovation PSG Labs will work closely with select partners in key technology ecosystems to accelerate the development of breakthrough innovations across three focus areas: Expanding PSG’s Global Innovation Footprint The launch of PSG Labs in Doha marks the first step in the Club’s international innovation expansion. The regional lab will serve as a gateway to emerging technology in the Middle East, allowing PSG to: “This is a major step in PSG’s innovation journey”, added Jerry Newman, Chief Digital and Innovation Officer of Paris Saint-Germain. “By launching this innovation lab in Doha, PSG is demonstrating the impact that visionary leadership and global collaboration can have in shaping the future of sports.” Join the Movement Applications for PSG Labs are now open. Startups and scaleups looking to shape the future of sports, media, and fan engagement are invited to apply. For more information, visit PSG Labs Official Website: https://www.psg.fr/labs
